Press Releases

March 19, 2019

Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene

March 5, 2019

Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene

February 28, 2019

Bristol-Myers Squibb Issues Statement in Response to Starboard’s Letter

February 22, 2019

Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene

February 20, 2019

Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene

January 3, 2019

Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company